CORVUS PHARMACEUTICALS
8.9200
25-十一月-24 15:18:28
15 分钟延时
股票
-0.0300
-0.34%
今日范围
8.9200 - 9.3529
ISIN
N/A
来源
NASDAQ
-
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
16 8月 2021 17:00:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
02 8月 2021 16:05:01 条件 Nasdaq GlobeNewswire
-
15 7月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
25 5月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
05 5月 2021 09:00:01 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
29 4月 2021 16:05:01 条件 Nasdaq GlobeNewswire
-
25 3月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
05 3月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
17 2月 2021 16:10:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 2月 2021 16:01:00 条件 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
04 2月 2021 07:30:00 条件 Nasdaq GlobeNewswire